Tag: immunotherapy
Search News
Protein level predicts immunotherapy response in bowel cancer
16th January 2025
Researchers have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy.
Read more
Scientists uncover protein with the power to help or hinder breast cancer progression
30th April 2024
The findings could help more patients to benefit from the latest advances in immunotherapies.
Read more
Immunotherapy drug improves survival for people with kidney cancer in landmark clinical trial
19th April 2024
Professor Tom Powles and team reveal first successful adjuvant therapy for kidney cancer in 50 years.
Read more
Dr Luigi Ombrato awarded Cancer Research UK grant to understand how the seeds of secondary tumours grow
21st March 2024
Congratulations to Dr Luigi Ombrato who has been awarded a £700k grant to investigate the earliest stages of cancer spread.
Read more
New drug combination doubles survival for people with bladder cancer
25th October 2023
Clinical trial results from BCI and Barts NHS trust provide new hope for people with bladder cancer.
Read more
The REMODEL project: Remodelling tumour microenvironments to improve immunotherapy
12th October 2022
Professor Fran Balkwill from Barts Cancer Institute at Queen Mary University of London has received a UK Research and Innovation (UKRI) Frontier Research grant of over £2 million to investigate the most effective ways to remodel cancers to enhance the effects of immunotherapy.
Read more